GALAXTRA Trademark

Trademark Overview


On Tuesday, April 25, 2017, a trademark application was filed for GALAXTRA with the United States Patent and Trademark Office. The USPTO has given the GALAXTRA trademark a serial number of 87424726. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, October 19, 2023. This trademark is owned by Solace Nutrition, LLC. The GALAXTRA trademark is filed in the Pharmaceutical Products category with the following description:

a white, soluble D-Galactose pharmaceutical powder for individuals with Congenital Disorders of Glycosylation (CDG disorders), such as Phosphoglucomutase 1 (PGM1) deficiency; dietary and nutritional supplements in the nature of white, soluble D-Galactose powder for individuals with Congenital Disorders of Glycosylation (CDG disorders), such as Phosphoglucomutase 1 (PGM1) deficiency; dietetic foods in the nature of a beverage powder that is white, soluble D-Galactose powder for individuals with Congenital Disorders of Glycosylation (CDG disorders), such as Phosphoglucomutase 1 (PGM1) deficiency
galaxtra

General Information


Serial Number87424726
Word MarkGALAXTRA
Filing DateTuesday, April 25, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 19, 2023
Registration Number5349492
Registration DateTuesday, December 5, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements


Goods and Servicesa white, soluble D-Galactose pharmaceutical powder for individuals with Congenital Disorders of Glycosylation (CDG disorders), such as Phosphoglucomutase 1 (PGM1) deficiency; dietary and nutritional supplements in the nature of white, soluble D-Galactose powder for individuals with Congenital Disorders of Glycosylation (CDG disorders), such as Phosphoglucomutase 1 (PGM1) deficiency; dietetic foods in the nature of a beverage powder that is white, soluble D-Galactose powder for individuals with Congenital Disorders of Glycosylation (CDG disorders), such as Phosphoglucomutase 1 (PGM1) deficiency

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 2, 2017
Primary Code005
First Use Anywhere DateTuesday, October 18, 2016
First Use In Commerce DateTuesday, October 18, 2016

Trademark Owner History


Party NameSolace Nutrition, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPawcatuck, CT 06379

Party NameSolace Nutrition, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPawcatuck, CT 06379

Party NameSolace Nutrition, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPawcatuck, CT 06379

Trademark Events


Event DateEvent Description
Thursday, October 19, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, October 19, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, October 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 13, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, December 5, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 5, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 26, 2017NON-FINAL ACTION E-MAILED
Wednesday, July 26, 2017NON-FINAL ACTION WRITTEN
Thursday, July 20, 2017ASSIGNED TO EXAMINER
Tuesday, May 2, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 28, 2017NEW APPLICATION ENTERED